NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 4 filers reported holding NEKTAR THERAPEUTICS in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,089 | -11.3% | 3,506,681 | -14.3% | 0.00% | +33.3% |
| Q2 2023 | $2,354 | +11.5% | 4,091,681 | +36.2% | 0.00% | 0.0% |
| Q1 2023 | $2,111 | +696.6% | 3,003,696 | +2464.8% | 0.00% | – |
| Q4 2022 | $265 | -100.0% | 117,111 | -64.2% | 0.00% | -100.0% |
| Q2 2019 | $11,636,000 | +68.6% | 327,048 | +59.2% | 0.01% | +66.7% |
| Q1 2019 | $6,903,000 | -47.8% | 205,448 | -48.9% | 0.01% | -57.1% |
| Q4 2018 | $13,212,000 | +214.8% | 401,948 | +483.8% | 0.01% | +250.0% |
| Q3 2018 | $4,197,000 | +197.9% | 68,848 | +138.7% | 0.00% | +300.0% |
| Q2 2018 | $1,409,000 | -74.3% | 28,848 | -68.6% | 0.00% | -83.3% |
| Q4 2017 | $5,485,000 | -12.2% | 91,848 | -83.8% | 0.01% | -53.8% |
| Q1 2015 | $6,249,000 | -6.7% | 568,048 | +31.4% | 0.01% | -18.8% |
| Q4 2014 | $6,698,000 | – | 432,148 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |